Local Tech Wire

DURHAM, N.C. – (Nasdaq:OXBT) has hired Jim Weiss to the newly-created position of sales director, the company announced this week.

In this position, he will be responsible for coordinating and implementing the strategy to market and sell the Company’s Dermacyte(TM) line of oxygen-enriched skin care products to physician’s offices, non-television direct marketing, and on the internet.

Effective May 24, he will report to Maria Isabel Tomargo, Assistant Vice President, Marketing and Sales.

Most recently, Weiss was a Marketing Practice Management consultant. Previously, he was district manager at NovaQuest Inc. as well as district business manager for Novo Nordisk Inc. and at CollaGenex Pharmaceuticals Inc.

"Jim’s background in creating, developing and motivating start-up sales teams will be an essential component for us to move forward with our two-tier model to market and sell our Dermacyte products," said Chris Stern, chairman and CEO of Oxygen Biotherapeutics.

Oxygen Biotherapeutics, Inc. is developing medical and cosmetic products that efficiently deliver oxygen to tissues in the body. The company has developed a proprietary perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product called Oxycyte(TM) that is being formulated for both intravenous and topical delivery.

Get the latest news alerts: at Twitter.